187 related articles for article (PubMed ID: 20829532)
1. Differentiation of intraductal growing-type cholangiocarcinomas from nodular-type cholangiocarcinomas at biliary MR imaging with MR cholangiography.
Kim JE; Lee JM; Kim SH; Baek JH; Moon SK; Yu IS; Kim SH; Lee JY; Han JK; Choi BI
Radiology; 2010 Nov; 257(2):364-72. PubMed ID: 20829532
[TBL] [Abstract][Full Text] [Related]
2. MR imaging findings of early bile duct cancer.
Lee DH; Lee JM; Kim KW; Park HS; Kim SH; Lee JY; Han JK; Choi BI
J Magn Reson Imaging; 2008 Dec; 28(6):1466-75. PubMed ID: 19025934
[TBL] [Abstract][Full Text] [Related]
3. The T1W hyperintense signal on the surface of distal segment of bile duct tumor thrombi and its significance.
Liu QY; Li HG; Gao M; Zhang WD; Lin XF
Acad Radiol; 2012 Sep; 19(9):1141-8. PubMed ID: 22709535
[TBL] [Abstract][Full Text] [Related]
4. Hilar cholangiocarcinoma: value of adding DW imaging to gadoxetic acid-enhanced MR imaging with MR cholangiopancreatography for preoperative evaluation.
Park MJ; Kim YK; Lim S; Rhim H; Lee WJ
Radiology; 2014 Mar; 270(3):768-76. PubMed ID: 24475800
[TBL] [Abstract][Full Text] [Related]
5. The value of gadobenate dimeglumine-enhanced hepatobiliary-phase MR imaging for the differentiation of scirrhous hepatocellular carcinoma and cholangiocarcinoma with or without hepatocellular carcinoma.
Jeon TY; Kim SH; Lee WJ; Lim HK
Abdom Imaging; 2010 Jun; 35(3):337-45. PubMed ID: 19350315
[TBL] [Abstract][Full Text] [Related]
6. Differential features of pancreatobiliary- and intestinal-type ampullary carcinomas at MR imaging.
Chung YE; Kim MJ; Park MS; Choi JY; Kim H; Kim SK; Lee M; Kim HJ; Choi JS; Song SY; Kim KW
Radiology; 2010 Nov; 257(2):384-93. PubMed ID: 20829529
[TBL] [Abstract][Full Text] [Related]
7. Autoimmune pancreatitis: pancreatic and extrapancreatic MR imaging-MR cholangiopancreatography findings at diagnosis, after steroid therapy, and at recurrence.
Manfredi R; Frulloni L; Mantovani W; Bonatti M; Graziani R; Pozzi Mucelli R
Radiology; 2011 Aug; 260(2):428-36. PubMed ID: 21613442
[TBL] [Abstract][Full Text] [Related]
8. Differentiating combined hepatocellular and cholangiocarcinoma from mass-forming intrahepatic cholangiocarcinoma using gadoxetic acid-enhanced MRI.
Hwang J; Kim YK; Park MJ; Lee MH; Kim SH; Lee WJ; Rhim HC
J Magn Reson Imaging; 2012 Oct; 36(4):881-9. PubMed ID: 22730271
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the longitudinal tumor extent of bile duct cancer: value of adding gadolinium-enhanced dynamic imaging to unenhanced images and magnetic resonance cholangiography.
Kim HJ; Lee JM; Kim SH; Han JK; Lee JY; Choi JY; Kim KH; Kim JY; Lee MW; Kim SJ; Choi BI
J Comput Assist Tomogr; 2007; 31(3):469-74. PubMed ID: 17538298
[TBL] [Abstract][Full Text] [Related]
10. Differentiation of infiltrative cholangiocarcinoma from benign common bile duct stricture using three-dimensional dynamic contrast-enhanced MRI with MRCP.
Yu XR; Huang WY; Zhang BY; Li HQ; Geng DY
Clin Radiol; 2014 Jun; 69(6):567-73. PubMed ID: 24581958
[TBL] [Abstract][Full Text] [Related]
11. Initial experience on utility of gadobenate dimeglumine (Gd-BOPTA) enhanced T1-weighted MR cholangiography in diagnosis of acute cholecystitis.
Akpinar E; Turkbey B; Karcaaltincaba M; Balli O; Akkapulu N; Balas S; Tirnaksiz B; Akata D; Akhan O
J Magn Reson Imaging; 2009 Sep; 30(3):578-85. PubMed ID: 19711404
[TBL] [Abstract][Full Text] [Related]
12. Cyst-forming intraductal papillary neoplasm of the bile ducts: description of imaging and pathologic aspects.
Lim JH; Zen Y; Jang KT; Kim YK; Nakanuma Y
AJR Am J Roentgenol; 2011 Nov; 197(5):1111-20. PubMed ID: 22021503
[TBL] [Abstract][Full Text] [Related]
13. Gadobutrol-enhanced, three-dimensional, dynamic MR imaging with MR cholangiography for the preoperative evaluation of bile duct cancer.
Ryoo I; Lee JM; Chung YE; Park HS; Kim SH; Han JK; Choi BI
Invest Radiol; 2010 Apr; 45(4):217-24. PubMed ID: 20195160
[TBL] [Abstract][Full Text] [Related]
14. MR imaging of intrahepatic cholangiocarcinoma with pathologic correlation.
Maetani Y; Itoh K; Watanabe C; Shibata T; Ametani F; Yamabe H; Konishi J
AJR Am J Roentgenol; 2001 Jun; 176(6):1499-507. PubMed ID: 11373220
[TBL] [Abstract][Full Text] [Related]
15. Intraductal papillary neoplasm of the bile duct: Assessment of invasive carcinoma and long-term outcomes using MRI.
Lee S; Kim MJ; Kim S; Choi D; Jang KT; Park YN
J Hepatol; 2019 Apr; 70(4):692-699. PubMed ID: 30553839
[TBL] [Abstract][Full Text] [Related]
16. Gadoxetate disodium-enhanced MRI of mass-forming intrahepatic cholangiocarcinomas: imaging-histologic correlation.
Jeong HT; Kim MJ; Chung YE; Choi JY; Park YN; Kim KW
AJR Am J Roentgenol; 2013 Oct; 201(4):W603-11. PubMed ID: 24059399
[TBL] [Abstract][Full Text] [Related]
17. Preoperative evaluation of bile duct cancer: MRI combined with MR cholangiopancreatography versus MDCT with direct cholangiography.
Park HS; Lee JM; Choi JY; Lee MW; Kim HJ; Han JK; Choi BI
AJR Am J Roentgenol; 2008 Feb; 190(2):396-405. PubMed ID: 18212225
[TBL] [Abstract][Full Text] [Related]
18. MRI manifestations of adult choledochal cysts associated with biliary malignancy: a report of ten cases.
Liu QY; Lai DM; Gao M; Wan YL; Lin XF; Li HG; Liang BL
Abdom Imaging; 2013 Oct; 38(5):1061-70. PubMed ID: 22926012
[TBL] [Abstract][Full Text] [Related]
19. Combined hepatocellular-cholangiocarcinoma: what the radiologist needs to know about biphenotypic liver carcinoma.
Shetty AS; Fowler KJ; Brunt EM; Agarwal S; Narra VR; Menias CO
Abdom Imaging; 2014 Apr; 39(2):310-22. PubMed ID: 24407728
[TBL] [Abstract][Full Text] [Related]
20. MRCP and 3D LAVA imaging of extrahepatic cholangiocarcinoma at 3 T MRI.
Li N; Liu C; Bi W; Lin X; Jiao H; Zhao P
Clin Radiol; 2012 Jun; 67(6):579-86. PubMed ID: 22137873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
